Patents Assigned to MIFCARE
  • MIF inhibitors
    Patent number: 10160732
    Abstract: Compounds of Formula (I?), and the use of the compounds of Formula (I?) as inhibitors of macrophage migration inhibitory factor (MIF). The use of compounds of Formula (I?) or pharmaceutical compositions thereof and method of using them, for treating disorders, diseases or conditions related to MIF.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: December 25, 2018
    Assignees: MIFCARE
    Inventors: Gael Jalce, Bernardin Akagah
  • MIF inhibitors for the acute or chronic treatment of pulmonary hypertension
    Patent number: 10071080
    Abstract: The present invention relates to the use of compounds of general Formula I and pharmaceutically acceptable enantiomers, salts or solvates thereof, for treating pulmonary hypertension in a subject.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: September 11, 2018
    Assignees: MIFCARE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITÉ PARIS-SUD 11
    Inventors: Gaël Jalce, Christophe Guignabert, Morane Le Hiress, Ly Tu, Bernardin Akagah